The production of monocyte chemoattractant protein-1 (MCP-1)/CCL2 in tumor microenvironments

Cytokine

Volumn 98, Issue , 2017, Pages 71-78

  Yoshimura, Teizo ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

CCL2; Chemokine; MCP 1; Tumor microenvironment

Indexed keywords

COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR SP1; UROKINASE; UROKINASE RECEPTOR; VASCULOTROPIN; CCL2 PROTEIN, HUMAN; CCL2 PROTEIN, MOUSE; CHEMOKINE; CHEMOTACTIC FACTOR; IL8 PROTEIN, HUMAN;

CELL MOTILITY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME MECHANISM; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE COUNT; NONHUMAN; OSTEOCLASTOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN RNA BINDING; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; UPREGULATION; GENE EXPRESSION REGULATION; IMMUNOLOGY; INFLAMMATION; ISOLATION AND PURIFICATION; LEUKOCYTE; MONOCYTE; NEUTROPHIL; PATHOPHYSIOLOGY;

CHEMOKINE CCL2; CHEMOKINES; CHEMOTACTIC FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; INTERLEUKIN-8; LEUKOCYTES; MONOCYTES; NEUTROPHILS; TUMOR MICROENVIRONMENT;

EID: 85011918299     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2017.02.001     Document Type: Review

References (71)

1. Yoshimura, T., Matsushima, K., Tanaka, S., Robinson, E.A., Appella, E., Oppenheim, J.J., Leonard, E.J., Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. U.S.A. 84 (1987), 9233–9237.
2. Yoshimura, T., Robinson, E.A., Tanaka, S., Appella, E., Kuratsu, J., Leonard, E.J., Purification and amino acid analysis of two human glioma cell-derived monocyte chemoattractants. J. Exp. Med. 169 (1989), 1449–1459.
3. Yoshimura, T., Robinson, E.A., Tanaka, S., Appella, E., Leonard, E.J., Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human peripheral blood mononuclear leukocytes. J. Immunol. 142 (1989), 1956–1962.
4. Matsushima, K., Larsen, C.G., DuBois, G.C., Oppenheim, J.J., Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169 (1989), 1485–1490.
5. Van Damme, J., Decock, B., Lenaerts, J.P., Conings, R., Bertini, R., Mantovani, A., Billiau, A., Identification by sequence analysis of chemotactic factors for monocytes produced by normal and transformed cells stimulated with virus, double-stranded RNA or cytokine. Eur. J. Immunol. 19 (1989), 2367–2373.
6. Murphy, P.M., Baggiolini, M., Charo, I.F., Hebert, C.A., Horuk, R., Matsushima, K., Miller, L.H., Oppenheim, J.J., Power, C.A., International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52 (2000), 145–176.
7. Boring, L., Gosling, J., Chensue, S.W., Kunkel, S.L., Farese, R.V. Jr., Broxmeyer, H.E., Charo, I.F., Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100 (1997), 2552–2561.
8. Kim, M.J., Tam, F.W., Urinary monocyte chemoattractant protein-1 in renal disease. Clin. Chim. Acta 412 (2011), 2022–2030.
9. Ansari, A.W., Heiken, H., Meyer-Olson, D., Schmidt, R.E., CCL2: a potential prognostic marker and target of anti-inflammatory strategy in HIV/AIDS pathogenesis. Eur. J. Immunol. 41 (2011), 3412–3418.
10. Panee, J., Monocyte chemoattractant protein 1 (MCP-1) in obesity and diabetes. Cytokine 60 (2012), 1–12.
11. Leonard, E.J., Meltzer, M.S., Characterization of mouse lymphocyte-derived chemotactic factor. Cell. Immunol. 26 (1976), 200–210.
12. Hayashi, H., Honda, M., Shimokawa, Y., Hirashima, M., Chemotactic factors associated with leukocyte emigration in immune tissue injury: their separation, characterization, and functional specificity. Int. Rev. Cytol. 89 (1984), 179–250.
13. Yoshimura, T., Honda, M., Hayashi, H., Selective chemotaxis of Ia-antigen positive blood monocytes in response to a macrophage chemotactic lymphokine extractable from PPD-induced delayed hypersensitivity reaction site in guinea pigs. Immunology 52 (1984), 269–280.
14. Bloom, B.R., Bennett, B., Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153 (1966), 80–82.
15. David, J.R., Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. U.S.A. 56 (1966), 72–77.
16. Altman, L.C., Chemotactic lymphokines: a review. Gallin, J.I., Quie, P.G., (eds.) Leukocyte Chemotaxis, 1978, Raven Press, New York, 267–287.
17. Zbar, B., Wepsic, H.T., Borsos, T., Rapp, H.J., Tumor-graft rejection in syngeneic guinea pigs: evidence for a two-step mechanism. J. Natl Cancer Inst. 44 (1970), 473–481.
18. Hibbs, J.B. Jr., The macrophage as a tumoricidal effector cell: a review of in vivo and in vitro studies on the mechanism of the activated macrophage nonspecific cytotoxic reaction. Fink, M.A., (eds.) The Macrophage in Neoplasia, 1976, Academic Press, New York, 83–89.
19. Ruco, L.P., Meltzer, M.S., Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of short-lived intermediary reactions. J. Immunol. 121 (1978), 2035–2042.
20. Salmon, S.E., Hamburger, A.W., Immunoproliferation and cancer: a common macrophage-derived promoter substance. Lancet 1 (1978), 1289–1290.
21. Currie, G.A., Promotion of fibrosarcoma cell growth by products of syngeneic host macrophages. Br. J. Cancer 44 (1981), 506–513.
22. Bottazzi, B., Polentarutti, N., Acero, R., Balsari, A., Boraschi, D., Ghezzi, P., et al. Regulation of the macrophage content of neoplasms by chemoattractants. Science 220 (1983), 210–212.
23. Evans, R., Haskill, S., Activities of macrophages within and peripheral to the tumor mass. Herberman, R.B., (eds.) The Reticuloendothelial System. A Comprehensive Treatise, vol. 5, 1983, Plenum Press, New York, 155–176.
24. Fidler, I.J., Macrophages and metastasis. Cancer Res. 45 (1985), 4714–4726.
25. Meltzer, M.S., Stevenson, M.M., Leonard, E.J., Characterization of macrophage chemotaxins in tumor cell cultures and comparison with lymphocyte-derived chemotactic factors. Cancer Res. 37 (1977), 721–725.
26. Yoshimura, T., Matsushima, K., Oppenheim, J.J., Leonard, E.J., Neutrophil chemotactic factor produced by lipopolysaccharide (LPS) stimulated human blood mononuclear leukocytes. Partial characterization and separation from interleukin 1 (IL 1). J. Immunol. 139 (1987), 788–793.
27. Kuratsu, J., Leonard, E.J., Yoshimura, T., Production and partial characterization of human glioma cell-derived monocyte chemotactic factor. J. Natl Cancer Inst. 81 (1989), 347–351.
28. Robinson, E.A., Yoshimura, T., Leonard, E.J., Tanaka, S., Griffin, P.R., Shabanowitz, J., Hunt, D.F., Appella, E., Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions. Proc. Natl. Acad. Sci. U.S.A. 86 (1989), 1850–1854.
29. Yoshimura, T., Yuhki, N., Moore, S.K., Appella, E., Lerman, M.I., Leonard, E.J., Human monocyte chemoattractant protein-1 (MCP-1): Full length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 244 (1989), 487–493.
30. Van Damme, J., Proost, P., Lenaerts, J.P., Opdenakker, G., Structural and functional identification of two human tumor derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J. Exp. Med. 176 (1992), 59–65.
31. Cochran, B.H., Reffel, A.C., Stiles, C.D., Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell 33 (1983), 939–947.
32. Rollins, B.J., Stier, P., Ernst, T., Wong, G.G., The human homolog of the JE gene encodes a monocyte secretory protein. Mol. Cell. Biol. 9 (1989), 4687–4695.
33. Bottazzi, B., Colotta, F., Sica, A., Nobili, N., Mantovani, A., A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF). Int. J. Cancer 45 (1990), 795–797.
34. Weiseman, B.S., Werb, Z., Stromal effects on mammary gland development and breast cancer. Science 296 (2002), 1046–1049.
35. Albini, A., Sporn, M.B., The tumour microenvironment as a target for chemoprevention. Nat. Rev. 7 (2007), 139–147.
36. Sund, M., Kalluri, R., Tumor stroma derived biomarkers in cancer. Cancer Metastasis Rev. 28 (2009), 177–183.
37. Li, X., Loberg, R., Liao, J., Ying, C., Snyder, L.A., Pienta, K.J., McCauley, L.K., A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone. Cancer Res. 69 (2009), 1685–1692.
38. Fujimoto, H., Sangai, T., Ishii, G., Ikehara, A., Nagashima, T., Miyazaki, M., Ochiai, A., Stromal MCP-1 in mammary tumors induces tumo-associated macrophage infiltration and contributes to tumor progression. Int. J. Cancer 125 (2009), 1276–1284.
39. Thanos, D., Maniatis, T., NF-kB: a lesson in family values. Cell 80 (1995), 529–532.
40. Li, Q., Verma, I.M., NF-kB regulation in the immune system. Nat. Immunol. 2 (2002), 725–734.
41. Prasad, S., Ravindran, J., Aggarwal, B.B., NF-kappaB and cancer: how intimate is this relationship. Mol. Cell. Biochem. 271 (2010), 25–37.
42. Grivennikov, S.I., Greten, F.R., Karin, M., Immunity, inflammation, and cancer. Cell 140 (2010), 883–899.
43. Ueda, A., Okuda, K., Ohno, S., Shirai, A., Igarashi, T., Matsunaga, K., Fukushima, J., Kawamoto, S., Ishigatsubo, Y., Okubo, T., NF- kappa B and Sp1 regulate transcription of human monocyte chemoattractant protein-1 gene. J. Immunol. 153 (1994), 2052–2063.
44. Ueda, A., Ishigatsubo, Y., Okubo, T., Yoshimura, T., Transcriptional regulation of the human monocyte chemoattractant protein-1 gene: cooperation of two NF-kB sites and NF-kB/rel subunit specificity. J. Biol. Chem. 272 (1997), 31092–31099.
45. Ping, D., Boekhoudt, G.H., Rogers, E.M., Boss, J.M., Nuclear factor-kB p65 mediates the assembly and activation of the TNF-responsive element of the murine monocyte chemoattractant-1 gene. J. Immunol. 162 (1999), 727–734.
46. Takeya, M., Yoshimura, T., Leonard, E.J., Kato, T., Okabe, H., Takahashi, K., Production of monocyte chemoattractant protein-1 (MCP-1) by malignant fibrous histiocytoma. Probable origin of histiocyte-like cells in the tumor. Exp. Mol. Pathol. 54 (1991), 61–71.
47. Safe, S., Abdelrahim, M., Sp transcription factor family and its role in cancer. Eur. J. Cancer 41 (2005), 2438–2448.
48. Wierstra, I., Sp1: Emerging roles-beyond constitutive activation of TATA-less housekeeping genes. Biochem. Biophys. Res. Commun. 372 (2008), 1–13.
49. Kalluri, R., Weinberg, R.A., The basics of epithlial-mesenchymal transition. J. Clin. Invest. 119 (2009), 1420–1428.
50. Low-Marchelli, J.M., Ardi, V.C., Vizcarra, E.A., van Rooijen, N., Quigley, J.P., Yang, J., Twist1 induces CCL2 and recruits macrophages to promote angiogenesis. Cancer Res. 73 (2013), 662–671.
51. Hsu, D.S., Wang, H.J., Tai, S.K., Chou, C.H., Hsieh, C.H., Chiu, P.H., Chen, N.J., Yang, M.H., Acetylation of snail modulates the cytokinome of cancer cells to enhance the recruitment of macrophages. Cancer Cell 26 (2014), 534–548.
52. Ottewell, P.D., The role of osteoblasts in bone metastasis. J. Bone Oncol. 5 (2016), 124–127.
53. Lu, Y., Cai, Z., Galson, D.L., Xiao, G., Liu, Y., George, D.E., Melhem, M.F., Yao, Z., Zhang, J., Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. Prostate 66 (2006), 1311–1318.
54. Heppner, G.H., Miller, F.R., Shekhar, P.V.M., Nontransgenic models of breast cancer. Breast Cancer Res. 2 (2000), 331–334.
55. Yoshimura, T., Howard, O.M.Z., Ito, T., Kuwabara, M., Matsukawa, A., Chen, K., Liu, Y., Liu, M., Oppenheim, J.J., Wang, J.M., Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells. PLoS ONE, 8, 2013, e58791, 10.1371/journal.pone.0058791.
56. Stathopoulos, G.T., Psallidas, I., Moustaki, A., Moschos, C., Kollintza, A., Karabela, S., Porfyridis, I., Vassiliou, S., Karatza, M., Zhou, Z., Joo, M., Blackwell, T.S., Roussos, C., Graf, D., Kalomenidis, I., A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion. J. Natl Cancer Inst. 100 (2008), 1464–1476.
57. Popivanova, B.K., Kostadinova, F.I., Furuichi, K., Shamekh, M.M., Kondo, T., Wada, T., Egashira, K., Mukaida, N., Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice. Cancer Res. 69 (2009), 7884–7892.
58. Qian, B.Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L.R., Kaiser, E.A., Snyder, L.A., Pollard, J.W., CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475 (2011), 222–225.
59. Green, J.E., Shibata, M.A., Yoshidome, K., Liu, M.L., Jorcyk, C., Anver, M.R., Wigginton, J., Wiltrout, R., Shibata, E., Kaczmarczyk, S., Wang, W., Liu, Z.Y., Calvo, A., Couldrey, C., The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene 19 (2000), 1020–1027.
60. Yoshimura, T., Imamichi, T., Weiss, J.M., Sato, M., Li, L., Matsukawa, A., Wang, J.M., Induction of monocyte chemoattractant proteins in macrophages via the production of granulocyte/macrophage colony-stimulating factor by breast cancer cells. Front. Immunol., 7, 2016, 2, 10.3389/fimmu.2016.00002.
61. Su, S., Liu, Q., Chen, J., Chen, J., Chen, F., He, C., Huang, D., Wu, W., Lin, L., Huang, W., Zhang, J., Cui, X., Zheng, F., Li, H., Yao, H., Su, F., Song, E., A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell 25 (2014), 605–620.
62. Yoshimura, T., Leonard, E.J., Secretion by human fibroblasts of monocyte chemoattractant protein-1 (MCP-1), the product of gene JE. J. Immunol. 144 (1990), 2377–2383.
63. Tsuyada, A., Chow, A., Wu, J., Somlo, G., Chu, P., Loera, S., Luu, T., Li, A.X., Wu, X., Ye, W., Chen, S., Zhou, W., Yu, Y., Wang, Y.Z., Ren, X., Li, H., Scherle, P., Kuroki, Y., Wang, S.E., CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. Cancer Res. 72 (2012), 2768–2779.
64. Yoshimura, T., Liu, M., Chen, X., Li, L., Wang, J.-M., Crosstalk between tumor cells and macrophages in stroma renders tumor cells as the primary source of MCP-1/CCL2 in Lewis lung carcinoma. Front. Immunol., 6, 2015, 332, 10.3389/fimmu.2015.00332.
65. Redon, C.E., Dickey, J.S., Nakamura, A.J., Kareva, I.G., Naf, D., Nowsheen, S., Kryston, T.B., Bonner, W.M., Georgakilas, A.G., Sedelnikova, O.A., Tumors induce complex DNA damage in distant proliferative tissues in vivo. Proc. Natl. Acad. Sci. U.S.A. 107 (2011), 17992–17997.
66. Zhu, J.F., Valente, A.J., Lorenzo, J.A., Carnes, D., Graves, D.T., Expression of monocyte chemoattractant protein 1 in human osteoblastic cells stimulated by proinflammatory mediators. J. Bone Miner. Res. 9 (1994), 1123–1130.
67. Kulbe, H., Thompson, R., Wilson, J.L., Robinson, S., Hagemann, T., Fatah, R., Gould, D., Ayhan, A., Balkwill, F., The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res. 67 (2007), 585–592.
68. Fridlender, Z.G., Kapoor, V., Buchlis, G., Cheng, G., Sun, J., Wang, L.C., Singhal, S., Snyder, L.A., Albelda, S.M., CCL2 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells. Am. J. Respir. Cell Mol. Biol. 44 (2011), 230–237.
69. Kim, S., Takahashi, H., Lin, W.W., Descargues, P., Grivennikov, S., Kim, Y., Luo, J.L., Karin, M., Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457 (2009), 102–106.
70. Cordero, J.B., Macagno, J.P., Stefanatos, R.K., Strathdee, K.E., Cagan, R.L., Vidal, M., Oncogenic Ras diverts a host TNF tumor suppressor activity into tumor promoter. Dev. Cell 18 (2010), 999–1011.
71. Popivanova, B.K., Kitamura, K., Wu, Y., Kondo, T., Kagaya, T., Kaneko, S., Oshima, M., Fujii, C., Mukaida, N., Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J. Clin. Invest. 118 (2008), 560–570.